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Abstract
Background: Human norovirus (NoV) causes more than 80% of nonbacterial gastroenteritis in
Europe and the United States. NoV transmission via contaminated surfaces may be significant for
the spread of viruses. Therefore, measures for prevention and control, such as surface disinfection,
are necessary to interrupt the dissemination of human NoV. Murine norovirus (MNV) as a
surrogate for human NoV was used to study the efficacy of active ingredients of chemical
disinfectants for virus inactivation on inanimate surfaces.
Methods: The inactivating properties of different chemical biocides were tested in a quantitative
carrier test with stainless steel discs without mechanical action. Vacuum-dried MNV was exposed
to different concentrations of alcohols, peracetic acid (PAA) or glutaraldehyde (GDA) for 5
minutes exposure time. Detection of residual virus was determined by endpoint-titration on RAW
264.7 cells.
Results: PAA [1000 ppm], GDA [2500 ppm], ethanol [50% (v/v)] and 1-propanol [30% (v/v)] were
able to inactivate MNV under clean conditions (0.03% BSA) on the carriers by ≥ 4 log10 within 5
minutes exposure time, whereas 2-propanol showed a reduced effectiveness even at 60% (v/v).
Furthermore, there were no significant differences in virus reduction whatever interfering
substances were used. When testing with ethanol, 1- and 2-propanol, results under clean
conditions were nearly the same as in the presence of dirty conditions (0.3% BSA plus 0.3%
erythrocytes).
Conclusion: Products based upon PAA, GDA, ethanol and 1-propanol should be used for NoV
inactivation on inanimate surfaces. Our data provide valuable information for the development of
strategies to control NoV transmission via surfaces.
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Background
Human noroviruses (NoVs) are members of the genus
Norovirus and belong to the family Caliciviridae possessing
a single-stranded genome without an envelope. NoV is
responsible for more than 80% of nonbacterial gastroen-
teritis in Europe and the United States [1,2]. The most
common routes of norovirus transmission are ingestion
of contaminated food or water, direct and indirect person-
to-person contact and aerosolization of viral particles.
In young children, a long-term shedding for more than
one month was observed in 22.6% of those with adequate
follow-up [3]. This study in a children's hospital also
revealed that 59% of all NoV infections were hospital-
acquired. A recent publication confirmed the extensive
contamination of environmental surfaces resulting in a
prolonged norovirus outbreak [4]. These findings high-
light the role of widespread environmental contamina-
tion in hospitals and other medical settings. Effective
disinfection of surfaces and healthcare equipment is cru-
cial for the prevention of virus transmission. Conse-
quently, inactivation studies simulating practical
conditions with different chemical biocides are important
to develop surface disinfectants effective against human
NoVs.
Due to the lack of a cell culture system for important
nosocomial pathogens such as human NoVs, it is neces-
sary to use a surrogate virus which can easily be cultivated
in cell culture. In the past, the most suitable surrogate for
human NoVs when studying the virucidal activity of
chemical disinfectants in suspension and on carriers was
the feline calicivirus (FCV) [5-7]. Within the family Cali-
civiridae, FCV belongs to the genus Vesivirus  and it is
known to be a respiratory pathogen. Therefore, survival
and inactivation characteristics may differ from those of
human NoVs, which are transmitted by the fecal-oral
route.
Recently, propagation of the murine norovirus (MNV) in
dendritic cells and macrophages was achieved [8]. Like
human NoV, MNV is a member of the genus Norovirus and
passes through the gastrointestinal tract. Because of this,
MNV seems to be a more suitable surrogate for human
NoV than FCV [9,10].
This study presents the results of activities of different bio-
cides against the MNV dried on stainless steel to simulate
practical conditions. These data should facilitate our
understanding of inactivation of human NoV by surface
disinfectants.
Methods
Preparation of the test virus suspension
Test virus suspension was prepared by infecting RAW
264.7 cells (ATCC TIB-71) with MNV (Berlin 06/06/DE
isolate S99, kindly provided by the Robert Koch-Institute
in Berlin) by using a multiplicity of infection of 1. Follow-
ing 2 hours of adsorption at 37°C, the inoculum was
replaced by Dulbecco's modified Eagle's medium
(DMEM, 4.5 g/l glucose, Lonza Group Ltd., Verviers, Bel-
gium) with 3% fetal calf serum (FCS, low endotoxin,
HyClone, PerbioScience, Bonn, Germany). The tissue cul-
ture flask was incubated at 37°C and 5% CO2 until 70–
95% of the cells showed a cytopathic effect (after 1–2
days). The cells were frozen and thawed twice, followed
by centrifugation at 1600 g for 10 minutes. The superna-
tant was aliquoted as test virus suspension and stored at -
80°C.
Chemical biocides
Dilutions of peracetic acid (PAA), glutaraldehyde (GDA)
and the different kinds of alcohol (Sigma-Aldrich, Seelze,
Germany) were prepared immediately before the inactiva-
tion experiments with hard water (300 ppm CaCO3, pH
7.0) prepared according to EN 14476:2007-02 and used
within 2 hours [11].
Preparation of virus inoculum
The virus inoculum was prepared by mixing the test virus
suspension with the interfering substances according to
EN 14476:2007-02 [11]:
a) Nine volumes of test virus suspension were mixed with
one volume of 0.3% w/v of bovine serum albumin (clean
conditions)
b) Nine volumes of test virus suspension were mixed with
one volume of 3% w/v of bovine serum albumin plus 3%
v/v washed sheep erythrocytes (dirty conditions).
Preparation of the carrier
For cleaning, stainless steel discs (20 mm diameter, GK
Formblech GmbH, Berlin, Germany) were incubated in a
5% (v/v) Decon®90-solution (Decon Laboratories Ltd.,
Hove, England) for 1 h. Afterwards the discs were rinsed
off twice with freshly destilled water for 10 sec, ensuring
that the carriers did not dry to any extent, and were then
placed in 70% ethanol (v/v) for 15 min. Finally, the carri-
ers were dried by evaporation in sterile petri dishes in a
biological safety cabinet.
Experimental procedure
50 μl of the virus inoculum were pipetted in the middle of
each pre-treated carrier and dried in a desiccator with a
vacuum of 700–800 mbar for about 30 minutes to reach
a constant humidity in all experiments. After drying, the
virus-contaminated discs were transferred into 25 ml plas-
tic vial holders (Sarstedt AG & Co. KG, Nümbrecht, Ger-
many), which were previously filled with 0.5 g of glass
beads (0.25–0.50 mm diameter, Carl Roth GmbH, Karl-
sruhe, Germany) to increase virus recovery by mechanicalBMC Infectious Diseases 2009, 9:107 http://www.biomedcentral.com/1471-2334/9/107
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abrasion. 100 μl of the test biocides were then pipetted on
the dried virus inoculum and incubated for 5 minutes.
Control carriers received 100 μl of hard water instead of
the chemical substance. In order to stop the activity of the
test substance, 900 μl of culture medium were added
immediately at the end of the exposure time. The vials
were vortexed directly for 1 min to recover the residual
virus before the eluate was diluted to determine viral
infectivity. Each test was carried out with 3 replicates (car-
riers) per concentration of the substance and virus control
respectively, with a minimum of two independent experi-
ments.
Determination of infectivity
Infectivity was determined by endpoint dilution titration
onto RAW 264.7 cells. At the end of the exposure time,
aliquots of the mixture were taken and diluted immedi-
ately. 100 μl of each dilution were placed in eight wells of
a sterile 96-well microtiter plate with the permissive RAW
264.7 cells. Plates were incubated for 4 to 5 days and
infectivity was analysed by virus-induced cytopathic
effect. Virus titres were determined by the method of
Spearman and Kärber. Titre reduction was calculated as
the difference between the virus titre of the water control
(5 min) and the titre of the biocides after 5 min of expo-
sure times and is presented as log10 reduction.
The criterion used for virucidal activity of the biocide was
a four log10  reduction in this study (inactivation of
99.99%).
Results
Inactivation of MNV by peracetic acid and glutaraldehyde
Different concentrations of PAA and GDA were evaluated
in the carrier test against MNV under clean conditions
with a contact time of 5 minutes. Concentrations of 50,
200 and 500 ppm were not able to reduce virus titres suf-
ficiently, whereas PAA in a concentration of 1000 ppm
reduced MNV titre by 4.05 log10. Testing GDA the concen-
tration had to be increased up to 2500 ppm to achieve a 4
log10 reduction in virus titre (Figure 1a and 1b). Lower
concentrations were not effective against the test virus on
the carriers.
Inactivation of MNV by different alcohols
Ethanol, 1-propanol and 2-propanol were tested for their
ability to inactivate MNV on stainless steel discs. These
different alcohols varied in their capability to inactivate
MNV under clean conditions. Whereas the highest used
concentration of 60% (v/v) 2-propanol only reduced the
viral titre by 3.02 log10 within 5 minutes of exposure time
(Figure 2a), 50–55% (v/v) ethanol was able to reduce the
infectivity of MNV by 4.09 to 6.18 log10 (Figure 2b). The
most effective alcohol in the carrier test was 1-propanol.
30% (v/v) 1-propanol was sufficient to inactivate 99.99%
of MNV after a contact time of 5 minutes. A concentration
of 40% (v/v) 1-propanol decreased virus titre on the car-
rier by an average of 6.04 log10 (Figure 2c).
Influence of soil load on MNV inactivation by different 
alcohols
To compare the influence of soil load, we analyzed the
three alcohols for their inactivation properties against
MNV under clean and dirty conditions. Reduction factors
achieved with the corresponding alcohols in concentra-
tions of 40% (v/v) and 60% (v/v) under clean conditions
were comparable to those measured under dirty condi-
tions (Figure 3).
Discussion
Norovirus infections spread rapidly particularly in senior
residences, hospitals, hotels, schools and even cruise
Effectiveness of peracetic acid and glutaraldehyde against murine norovirus Figure 1
Effectiveness of peracetic acid and glutaraldehyde against murine norovirus. a) 100 μl of peracetic acid [50, 200, 
500, 1000, 1500 ppm] or b) 100 μl of glutaraldehyde [125, 500, 1000, 2000, 2500 ppm] were pipetted on the dried virus inoc-
ulums (clean conditions) and incubated for 5 minutes. Results represent the mean log10 reduction with standard deviation of 
three replicates per concentration of the substance of two independent experiments.BMC Infectious Diseases 2009, 9:107 http://www.biomedcentral.com/1471-2334/9/107
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ships. Apparently, contaminated surfaces may play an
important role in the spread of human NoV [12-15]. In a
rehabilitation centre, the protracted course of norovirus-
induced gastroenteritis was also connected to an environ-
mental contamination [16]. Therefore, measures for the
prevention and control of NoV transmission should
include surface disinfection with products highly effective
against this viral pathogen.
Many surface cleaners in the household are based on 0.5%
hypochlorite. It was shown by reverse transcriptase
polymerase chain reaction (RT-PCR) for human NoVs
that the cleaning of fecally contaminated surfaces with a
cloth soaked in detergents or treatment with 0.5%
hypochlorite alone failed to eliminate human NoVs. The
virus could still be detected on up to 28% of the surfaces
by RT-PCR. Only wiping the surface with a cloth soaked in
detergents followed by applying a combined hypochlo-
rite/detergent treatment was successful to achieve a suffi-
cient efficacy against human NoVs [17].
Since there is only limited knowledge about human NoV
inactivation on surfaces, it was the aim of this study to
evaluate the virucidal properties of some often-used
chemical ingredients of surface disinfectants in a stand-
ardized test procedure. The importance of carrier-based
methods to test efficacy of disinfectants against vertebrate
viruses has been stressed [18].
Meanwhile, carrier test methods including a ring trial
launched under the initiative of the Organisation for Eco-
nomic Cooperation and Development have been pub-
lished [19-21]. In our study the protocol used followed
the draft of the European Committee for Standardization
TC 216 with 0.03% BSA and 0.3% BSA plus 0.3% sheep
erythrocytes as interfering substances without mechanical
action [22].
The absence of a cell culture assay for human NoV makes
it necessary to introduce a reliable surrogate virus when
studying the environmental persistence and efficacy of
chemical disinfectants. Because FCV can be propagated in
cell culture, it has been extensively studied in inactivation
studies in the past [5,23]. In contrast to FCV, MNV is
transmitted by the fecal-oral route, thus making this virus
a promising surrogate for human NoVs. Consequently,
stability and inactivation by alcohol-based hand rubs and
commercial products used in veterinary medicine for sur-
face disinfection have been successfully tested with MNV
in suspension and carrier tests [24-26].
In this study, MNV showed a remarkable stability while
drying. The difference in the virus titre before and after
drying on the carrier did not exceed 0.35 log10 (data not
shown in table). In contrast, the poliovirus titre decreased
by about 3 log10 during the drying process [27].
In general, non-enveloped viruses can persist for approxi-
mately up to two months on inanimate surfaces [28]. For
example, reovirus was able to survive on polyvinyl chlo-
ride carriers for a period of 30 days dried in organic matrix
[29].
Effectiveness of different concentrations of 2-propanol, ethanol and 1-propanol against murine norovirus Figure 2
Effectiveness of different concentrations of 2-propanol, ethanol and 1-propanol against murine norovirus. a) 
100 μl of 2-propanol [20, 30, 40, 50, 60% (v/v)], b) 100 μl of ethanol [40, 45, 50, 55, 60% (v/v)] or c) 100 μl of 1-propanol [10, 
20, 30, 40, 50, 60% (v/v)] were pipetted on the dried virus inoculums (clean conditions) and incubated for 5 minutes. Results 
represent the mean log10 reduction with standard deviation of three replicates per concentration of the substance of two inde-
pendent experiments.BMC Infectious Diseases 2009, 9:107 http://www.biomedcentral.com/1471-2334/9/107
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MNV can persist in various environmental conditions.
After 40 days at -20°C and 4°C only a < 2 log10 reduction
was observed [30]. This study also revealed that MNV sur-
vived better in a stool suspension than on the surface of
gauze or diaper material.
Recently, the stability of MNV mixed with artificial feces
on stainless steel coupons was studied [25]. In this study,
only a minimal loss of infectivity was measured at pH 2,
whereas FCV was rather unstable at pH values lower
than 3.
In this study we show that PAA and GDA were able to
reduce the titre of MNV under clean conditions about
more than 4 log10 within 5 minutes of exposure time.
When testing PAA a concentration of 0.1% (1000 ppm)
and when testing GDA a concentration of 0.25% (2500
ppm) was needed to inactivate 99.99% of the viruses.
These results were confirmed by the ability of two com-
mercial products based upon GDA and PAA to inactivate
MNV [26].
In tests with other viruses simulating practical conditions,
2.0% GDA was able to inactivate HIV, rotavirus and HAV
on carriers within one minute [31-33]. Additionally, reo-
virus embedded in an artificial test soil was inactivated by
GDA within one minute, whereas a concentration of 0.1%
took 12 minutes to inactivate this virus completely [29].
Generally, besides PAA and GDA, chlorine-based prod-
ucts are often recommended to inactivate non-enveloped
viruses on contaminated inanimate surfaces. Testing non-
porous and porous surfaces, 20 to 200 ppm of hypochlo-
rous acid solution reduced the titres of human NoV and
MNV by 3 log10 within a contact time of 10 minutes [34].
In further experiments we analysed the virucidal proper-
ties of ethanol, 1-propanol and 2-propanol against MNV
in the quantitative carrier test under clean conditions with
concentrations from 10 to 60% (v/v). Since results from
the suspension test with the MNV where ethanol in a con-
centration of 60% (v/v) to 80% (v/v) was more effective
than 1-propanol followed by 2-propanol (unpublished),
we expected ethanol to be the most effective virucidal
agent, followed by 1- and 2-propanol. Surprisingly, 1-pro-
panol was the most effective alcohol to inactivate MNV on
the carrier under clean conditions. Interestingly, a concen-
tration of only 30% (v/v) 1-propanol was sufficient to
inactivate 99.99% of the virus. In comparison, the two
other alcohols were completely ineffective at this concen-
tration. Ethanol achieved a similar effectiveness only at
50–55% (v/v), while 2-propanol at a concentration of
60% (v/v) did not reach a 4 log10 reduction. These results
are in contrast to data with FCV. Here, 2-propanol inacti-
vating 99% within one minute at 40 to 60% was found to
be more effective than ethanol (6).
Approaching practical conditions, the soil load was
increased from 0.03% BSA (clean conditions) to 0.3%
BSA plus 0.3% sheep erythrocytes (dirty conditions). Pre-
vious results of suspension tests or carrier assays had
shown that a higher organic load resulted in a decreased
Comparison of the inactivation properties of different alcohols under clean and dirty conditions Figure 3
Comparison of the inactivation properties of different alcohols under clean and dirty conditions. 100 μl of etha-
nol [40, 60% (v/v)], 1-propanol [40, 60% (v/v)] or 2-propanol [40, 60% (v/v)] were pipetted on the dried virus inoculums and 
incubated for 5 minutes. Results represent the mean log10 reduction with standard deviation of two replicates per concentra-
tion of the substance of two independent experiments.BMC Infectious Diseases 2009, 9:107 http://www.biomedcentral.com/1471-2334/9/107
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effectiveness of the biocide [35-37]. Interestingly, our
results could not confirm these findings. There was no dif-
ference in log10 reduction detectable between clean and
dirty conditions. All three alcohols tested showed similar
reduction factors at 40% (v/v) and 60% (v/v) with 0.03%
BSA as well as with 0.3% BSA plus 0.3% erythrocytes. At
the tested concentration of 40% (v/v) 1-propanol was
highly active against MNV after an exposure time of 5
minutes by reaching a reduction of 6 log10, whereas etha-
nol and 2-propanol could not inactivate the virus suffi-
ciently. The effectiveness of ethanol and 2-propanol could
be enhanced by increasing the concentration of alcohol.
At an alcohol concentration of 60% (v/v) ethanol reached
an efficacy comparable to 1-propanol, whereas 2-propa-
nol was not capable of reducing the virus titre by more
than 3 log10 at the same concentration.
In summary, our data indicate that 1-propanol was the
most effective alcohol to inactivate MNV on stainless steel
discs within 5 minutes of contact time. Independent of
the amount of soil load, even a concentration of 30% (v/
v) 1-propanol had the capability to decrease the virus titre
by ≥ 4 log10 within 5 minutes.
In further studies, it would be interesting to compare the
inactivating properties of these biocides against MNV on
other carriers often used in hospitals and other medical
settings.
Conclusion
To interrupt the transmission of human NoV it is neces-
sary to use highly effective surface disinfectants tested
under practical conditions. Our results show that MNV as
a surrogate for human NoV is inactivated under clean con-
ditions by PAA and GDA as well as by the two alcohols
ethanol and 1-propanol on stainless steel discs after 5
minutes of exposure time, whereas 2-propanol only
achieved insufficient effectiveness. The effective concen-
trations of the chemical biocides examined provide an
informative basis when evaluating these substances as
possible active ingredients of surface disinfectants with
short contact times.
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